| scholarly article | Q13442814 |
| P50 | author | Yuri V Bobryshev | Q88065781 |
| P2093 | author name string | Colin-John Perrins | |
| P2860 | cites work | Journal of Experimental Medicine | Q3186912 |
| Blood monocytes: development, heterogeneity, and relationship with dendritic cells | Q24314793 | ||
| Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution | Q24679240 | ||
| The biology of NKT cells | Q28277482 | ||
| The pathogenesis of atherosclerosis: a perspective for the 1990s | Q29547827 | ||
| Tolerogenic dendritic cells | Q29618755 | ||
| HMG-CoA reductase inhibitors suppress maturation of human dendritic cells: new implications for atherosclerosis | Q33196578 | ||
| Emergence of dendritic cells in rupture-prone regions of vulnerable carotid plaques | Q33205809 | ||
| Dendritic cells in atherosclerotic disease | Q33651897 | ||
| Glycolipid presentation to natural killer T cells differs in an organ-dependent fashion | Q33762686 | ||
| The vascular-associated lymphoid tissue: a new site of local immunity | Q34372310 | ||
| Dendritic cells: immune regulators in health and disease | Q34482541 | ||
| Interleukin-10 deficiency increases atherosclerosis, thrombosis, and low-density lipoproteins in apolipoprotein E knockout mice. | Q34520320 | ||
| Intrasplenic steady-state dendritic cell precursors that are distinct from monocytes | Q34522666 | ||
| Dendritic cell subsets in health and disease. | Q34582889 | ||
| Steady-state and inflammatory dendritic-cell development | Q34591334 | ||
| Friendly and dangerous signals: is the tissue in control? | Q34593031 | ||
| Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis | Q34737721 | ||
| Hallmarks of atherosclerotic lesion development with special reference to immune inflammatory mechanisms | Q34930182 | ||
| Dendritic Cell Function in Vivo during the Steady State: A Role in Peripheral Tolerance | Q35119879 | ||
| Autoimmune and inflammatory mechanisms in atherosclerosis | Q35698466 | ||
| The role of interleukin-4 and interleukin-12 in the progression of atherosclerosis in apolipoprotein E-deficient mice | Q35792034 | ||
| Natural killer T cells as targets for immunotherapy of autoimmune diseases | Q35798168 | ||
| Detection of activated T lymphocytes in the human atherosclerotic plaque | Q35817589 | ||
| Linking immune-mediated arterial inflammation and cholesterol-induced atherosclerosis in a transgenic mouse model | Q35824235 | ||
| Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens | Q35826361 | ||
| Progress in the development of immunotherapy of cancer using ex vivo-generated dendritic cells expressing multiple tumor antigen epitopes. | Q35922431 | ||
| Dendritic cell-mediated T cell polarization | Q35988802 | ||
| Dendritic cells in atherosclerosis: current status of the problem and clinical relevance | Q36108241 | ||
| Low-grade chronic inflammation in regions of the normal mouse arterial intima predisposed to atherosclerosis | Q36228893 | ||
| Production of type I interferons: plasmacytoid dendritic cells and beyond | Q36231531 | ||
| The yin and yang of type I interferon activity in bacterial infection | Q36234715 | ||
| Monocyte recruitment and foam cell formation in atherosclerosis | Q36344829 | ||
| Human dendritic cell subsets for vaccination | Q36354718 | ||
| Inflammation and atherosclerosis: novel insights into plaque formation and destabilization | Q36495025 | ||
| Participatory role of natural killer and natural killer T cells in atherosclerosis: lessons learned from in vivo mouse studies | Q36538364 | ||
| NKT cells: T lymphocytes with innate effector functions | Q36788766 | ||
| Oxidized LDL antibodies in treatment and risk assessment of atherosclerosis and associated cardiovascular disease | Q36789663 | ||
| Immune-mediated mechanisms in atherosclerosis: prevention and treatment of clinical manifestations | Q37066269 | ||
| Identification of antigen-presenting dendritic cells in mouse aorta and cardiac valves | Q37234314 | ||
| Regulation of MHC II and CD1 antigen presentation: from ubiquity to security. | Q37276471 | ||
| Atherosclerosis--an immune disease: The Anitschkov Lecture 2007. | Q37308326 | ||
| Dendritic cell subtypes as primary targets of vaccines: the emerging role and cross-talk of pattern recognition receptors | Q37309247 | ||
| The therapeutic potential of targeting B cells and anti-oxLDL antibodies in atherosclerosis | Q37414502 | ||
| Vaccination against atherosclerosis? Induction of atheroprotective immunity | Q37495603 | ||
| The discovery of cellular immunity in the atherosclerotic plaque | Q37619147 | ||
| Dendritic cells and their role in atherogenesis | Q37748449 | ||
| TLR signaling and trapped vascular dendritic cells in the development of atherosclerosis | Q40337625 | ||
| Vascular dendritic cells as gatekeepers of lipid accumulation within nascent atherosclerotic plaques | Q42801094 | ||
| CD11c(+) dendritic cells maintain antigen processing, presentation capabilities, and CD4(+) T-cell priming efficacy under hypercholesterolemic conditions associated with atherosclerosis | Q43145952 | ||
| Dendritic cells pulsed with malondialdehyde modified low density lipoprotein aggravate atherosclerosis in Apoe(-/-) mice | Q43246351 | ||
| Resident intimal dendritic cells accumulate lipid and contribute to the initiation of atherosclerosis. | Q43247649 | ||
| Vaccination using oxidized low-density lipoprotein-pulsed dendritic cells reduces atherosclerosis in LDL receptor-deficient mice. | Q43263819 | ||
| Identification of dendritic cells in aortic atherosclerotic lesions in rats with diet-induced hypercholesterolaemia | Q43871831 | ||
| Induction of a regulatory T cell type 1 response reduces the development of atherosclerosis in apolipoprotein E-knockout mice | Q44545474 | ||
| Depletion of natural killer cell function decreases atherosclerosis in low-density lipoprotein receptor null mice | Q44779169 | ||
| Dyslipidemia associated with atherosclerotic disease systemically alters dendritic cell mobilization | Q45107482 | ||
| Conventional dendritic cells at the crossroads between immunity and cholesterol homeostasis in atherosclerosis | Q46043752 | ||
| Treatment with apo B peptide vaccines inhibits atherosclerosis in human apo B-100 transgenic mice without inducing an increase in peptide-specific antibodies | Q46376396 | ||
| Transient role for CD1d-restricted natural killer T cells in the formation of atherosclerotic lesions | Q46711267 | ||
| Mapping of vascular dendritic cells in atherosclerotic arteries suggests their involvement in local immune-inflammatory reactions | Q47863833 | ||
| Most lymphoid organ dendritic cell types are phenotypically and functionally immature. | Q52104466 | ||
| Vaccination against Foxp3(+) regulatory T cells aggravates atherosclerosis. | Q53370200 | ||
| Decreased number of circulating plasmacytoid dendritic cells in patients with atherosclerotic coronary artery disease. | Q53620982 | ||
| Toll-like receptor-4 and mitogen-activated protein kinase signal system are involved in activation of dendritic cells in patients with acute coronary syndrome. | Q54539959 | ||
| Ultrastructural recognition of cells with dendritic cell morphology in human aortic intima. Contacting interactions of Vascular Dendritic Cells in athero-resistant and athero-prone areas of the normal aorta. | Q54706220 | ||
| Natural regulatory T cells control the development of atherosclerosis in mice | Q58149268 | ||
| Distinct Roles of Dendritic Cells and B Cells in Va14Ja18 Natural T Cell Activation In Vivo | Q63363302 | ||
| Interleukin-10 blocks atherosclerotic events in vitro and in vivo | Q64381132 | ||
| Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque | Q69990504 | ||
| Transfer of CD4(+) T cells aggravates atherosclerosis in immunodeficient apolipoprotein E knockout mice | Q73288555 | ||
| Can dendritic cells be exploited for therapeutic intervention in atherosclerosis? | Q73660885 | ||
| Evidence that dendritic cells infiltrate atherosclerotic lesions in apolipoprotein E-deficient mice | Q74392978 | ||
| The role of interleukin 12 in the development of atherosclerosis in ApoE-deficient mice | Q74598506 | ||
| Effects of oxidised low density lipoprotein on dendritic cells: a possible immunoregulatory component of the atherogenic micro-environment? | Q74604330 | ||
| Functional profile of activated dendritic cells in unstable atherosclerotic plaque | Q79394681 | ||
| Role of naturally occurring CD4+ CD25+ regulatory T cells in experimental atherosclerosis | Q79711302 | ||
| Promise of immune modulation to inhibit atherogenesis | Q80747676 | ||
| Co-accumulation of dendritic cells and natural killer T cells within rupture-prone regions in human atherosclerotic plaques | Q81802868 | ||
| Dendritic cells in vivo: a key target for a new vaccine science | Q81980748 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | atherosclerosis | Q12252367 |
| P304 | page(s) | 117-123 | |
| P577 | publication date | 2010-11-11 | |
| P1433 | published in | Virchows Archiv | Q19059548 |
| P1476 | title | Current advances in understanding of immunopathology of atherosclerosis | |
| P478 | volume | 458 |
| Q58788694 | An Ex Vivo Vessel Injury Model to Study Remodeling |
| Q35525108 | Atherosclerosis in systemic lupus erythematosus |
| Q34640247 | Coagulation activation, depletion of platelet granules and endothelial integrity in case of uraemia and haemodialysis treatment |
| Q37985757 | Contribution of monocyte-derived macrophages and smooth muscle cells to arterial foam cell formation |
| Q36937435 | High glucose induces upregulation of scavenger receptors and promotes maturation of dendritic cells |
| Q48060946 | In silico and In vitro evaluation of the anti-inflammatory potential of Centratherum punctatum Cass-A. |
| Q37527721 | Novel Multifunctional Nanomatrix Reduces Inflammation in Dynamic Conditions in Vitro and Dilates Arteries ex Vivo |
| Q49425306 | Oxidized low density lipoprotein facilitates tumor necrosis factor‑α mediated chondrocyte death via autophagy pathway |
| Q36064574 | Plasmacytoid dendritic cells in atherosclerosis |
| Q34795467 | Recombinant Cpn 0810 stimulates proinflammatory cytokine expression and apoptosis in human monocytes |
| Q26801649 | Role of gut microbiota in the modulation of atherosclerosis-associated immune response |
| Q33646549 | Salvia miltiorrhiza: A Potential Red Light to the Development of Cardiovascular Diseases |
Search more.